Exicure News and Activities

Exicure is a company listed under the stock ticker XCUR (US).

View the org chart displaying its 10 main executives

Most searched biographies at Exicure

• Jung Soo Kim, Chief Executive Officer
• Jin Young Go, Director
• Gyeong Seog Cheon, Director

Popular executive movements at Exicure

• Jin Young Go has joined the company as Director  (posted on July 2 2026).
• Eui Seok Han has joined the company as Director  (posted on July 2 2026).
• Jung Kyu Ham, Director, has left the company  (posted on July 2 2026).

Create your alert
to follow the executive moves at Exicure.

Exicure has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Exicure

• Exicure, Inc. Receives Extension from Nasdaq Hearings Panel
• Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation
• Exicure, Inc. Announces 1-for-5 Reverse Stock Split
• Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting
• Exicure, Inc. Reports Second Quarter 2024 Financial Results
• Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting
• Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics
• Exicure, Inc. Receives Positive Listing Determination from Nasdaq
• Exicure, Inc. Reports Full Year 2023 Financial Results
• Exicure, Inc. Received Nasdaq Notice of a Delisting Determination
• View more press releases Close

Social media about Exicure

• Exicure on Wikipedia, Google News & Yahoo Finance
• Exicure on LinkedIn, X (Twitter) & YouTube